From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Supply@Me Capital – a master class in avoiding answering AGM questions

By Tom Winnifrith | Sunday 19 September 2021


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


The fraud Supply@ME Capital (SYME) held its AGM on 3 July and it took until 16 September to provide responses to the questions raised by the morons who own its shares.  Admittedly there were 182 questions but there was a large degree of overlap in the questions and Supply resorted to standard answers for many of the questions.  For instance, 22 questions related to trading (numbers Q27, Q40, Q44, Q69, Q73, Q77, Q87, Q118, Q121, Q122, Q123, Q124, Q135, Q140, Q141, Q146, Q156, Q166, Q168, Q169, Q174, Q178) were answered with a one sentence reply essentially stating refer to revenue guidance.  Similarly, 12 questions on Negma convertible loan note (Q67, Q82, Q83, Q95, Q96, Q97, Q112, Q120, Q125, Q126, Q161, Q172 were answered with the statement “The Company recently updated the market regarding the termination of the Negma arrangement.”

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:56:44